Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 7/20 | 0.70 |
| ▸ | GSK3A | P49840 | 2/20 | 0.70 |
| ▸ | AAK1 | Q2M2I8 | 8/20 | 0.64 |
| ▸ | ACHE | P22303 | 3/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | GAK | O14976 | 1/20 | 0.54 |
| ▸ | STK16 | O75716 | 1/20 | 0.54 |
| ▸ | BMP2K | Q9NSY1 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4483041 | 0.91 | GSK3B (0.67) | GSK3BGSK3AAAK1ACHECYP1A2 | |
| SCHEMBL4500329 | 0.90 | GSK3B (0.68) | GSK3BGSK3AAAK1CYP1A2GAK | |
| SCHEMBL4479320 | 0.88 | AAK1 (0.64) | GSK3BGSK3AAAK1ACHECYP1A2 | |
| SCHEMBL4502834 | 0.86 | GSK3B (0.70) | GSK3BGSK3AAAK1ACHECYP1A2 | |
| SCHEMBL4480795 | 0.86 | AAK1 (0.61) | GSK3BGSK3AAAK1ACHECYP1A2 | |
| SCHEMBL4483758 | 0.85 | HDAC1 (0.67) | GSK3BGSK3AAAK1ACHEHDAC1 | |
| SCHEMBL4476051 | 0.85 | GSK3B (0.91) | GSK3BGSK3AAAK1GAKSTK16 | |
| SCHEMBL4493309 | 0.85 | HDAC6 (0.63) | GSK3BGSK3AAAK1ACHEGAK | |
| SCHEMBL4486080 | 0.84 | GSK3B (0.66) | GSK3BGSK3AAAK1ACHECYP1A2 | |
| SCHEMBL4506175 | 0.84 | AAK1 (0.58) | GSK3BGSK3AAAK1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |